GENEXT Genomics PVT LTD, incorporated in 2011 and functional in 2014 with a BIG BIRAC GRANT, is a research-based company specializing in protein engineering. Initially aiming to fill a gap in antibody manufacturing, GENEXT envisioned becoming a pioneer in antibody development. The company currently commercializes a portfolio of proteins and antibodies for research use only (RUO), supported by Indian and international distributors and OEM partners. Leveraging its expertise, GENEXT has expanded its focus to developing antibodies of diagnostic and therapeutic importance.